Is Chemed the Perfect Stock?

Every investor would love to stumble upon the perfect stock. But will you ever really find a stock that provides everything you could possibly want?

One thing's for sure: You'll never discover truly great investments unless you actively look for them. Let's discuss the ideal qualities of a perfect stock, then decide if Chemed (NYSE: CHE  ) fits the bill.

The quest for perfection
Stocks that look great based on one factor may prove horrible elsewhere, making due diligence a crucial part of your investing research. The best stocks excel in many different areas, including these important factors:

  • Growth. Expanding businesses show healthy revenue growth. While past growth is no guarantee that revenue will keep rising, it's certainly a better sign than a stagnant top line.
  • Margins. Higher sales mean nothing if a company can't produce profits from them. Strong margins ensure that company can turn revenue into profit.
  • Balance sheet. At debt-laden companies, banks and bondholders compete with shareholders for management's attention. Companies with strong balance sheets don't have to worry about the distraction of debt.
  • Money-making opportunities. Return on equity helps measure how well a company is finding opportunities to turn its resources into profitable business endeavors.
  • Valuation. You can't afford to pay too much for even the best companies. By using normalized figures, you can see how a stock's simple earnings multiple fits into a longer-term context.
  • Dividends. For tangible proof of profits, a check to shareholders every three months can't be beat. Companies with solid dividends and strong commitments to increasing payouts treat shareholders well.

With those factors in mind, let's take a closer look at Chemed.

Factor

What We Want to See

Actual

Pass or Fail?

Growth 5-Year Annual Revenue Growth > 15% 6.4% Fail
  1-Year Revenue Growth > 12% 7.6% Fail
Margins Gross Margin > 35% 28.7% Fail
  Net Margin > 15% 6.2% Fail
Balance Sheet Debt to Equity < 50% 38.7% Pass
  Current Ratio > 1.3 1.05 Fail
Opportunities Return on Equity > 15% 17.3% Pass
Valuation Normalized P/E < 20 13.02 Pass
Dividends Current Yield > 2% 1.3% Fail
  5-Year Dividend Growth > 10% 19.3% Pass
       
  Total Score   4 out of 10

Source: S&P Capital IQ. Total score = number of passes.

With a score of four, Chemed falls well short of the top of our scale. The company has faced some scary allegations lately, but those fears have pushed valuations down to very attractive levels.

Chemed is a bit of an odd duck as companies go. Of Chemed's businesses, the typical person is probably most familiar with its Roto-Rooter plumbing and drain repair segment. But the company also runs facilities that provide hospice care to dying patients. That has been a profitable combination, and earlier this year, Chemed was able to boost its dividend by 14% to its current level.

Health care in particular is a tough place to invest, especially in recent times. Concerns about changing health-care regulations and reimbursement practices have made home health stocks like Amedisys (Nasdaq: AMED  ) , Gentiva Health (Nasdaq: GTIV  ) , and Almost Family (Nasdaq: AFAM  ) veritable minefields for shareholders. While not strictly comparable, Chemed is also vulnerable to the same trends.

Earlier this week, Chemed shares dropped more than 10% after a whistleblowing former manager sued the company with allegations of conspiracy involving Chemed's hospice care business. With the Department of Justice also investigating suspicions that Chemed unit Vitas allegedly defrauded Medicare and Medicaid, investors are understandably edgy.

For Chemed to keep improving, it needs to get out from under the clouds of regulatory scrutiny and reestablish itself as a strong business. Fortunately, the stock has a reasonable valuation right now, so if it can restore its reputation, Chemed could well get back toward perfection in the years ahead -- if it's given enough time to do so.

Keep searching
No stock is a sure thing, but some stocks are a lot closer to perfect than others. By looking for the perfect stock, you'll go a long way toward improving your investing prowess and learning how to separate out the best investments from the rest.

Click here to add Chemed to My Watchlist, which can find all of our Foolish analysis on it and all your other stocks.

Finding the perfect stock is only one piece of a successful investment strategy. Get the big picture by taking a look at our "13 Steps to Investing Foolishly."

Fool contributor Dan Caplinger doesn't own shares of the companies mentioned. The Motley Fool owns shares of Almost Family. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Fool has a disclosure policy.


Read/Post Comments (1) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On November 27, 2011, at 10:13 AM, thefixerisin wrote:

    Chemed is being investigated for frauding the federal governemt with its Vistas hospice.;Chemed corporation has been tight lipped about its Roto Rooter operations too. On Nov 9th a Massachusetts Superior court judge refused RR's motion to dismiss all 12 counts against them in a suit that alleges they were using unlicensed people posing as plumbers in the Commonwealth. Massachusetts. State law mandates that all plumbing work be performed by a licensed Plumber. The Dept of licensure and State Board of Examiners of Plumbers and Gas-fitters is investigating on behalf of the consumers of Massachusetts. In Minnesota a class action just arose in regards to un-needed sewer repairs and aggressive sales tactics used to fraud the consumers of Minnesota. Then in Fderal court Chemed is being sued for failing to pay its Roto Rooter employees Minimum wage,overtime,un-recorded time and making them carry the business expenses of the company,this case is now past discovery and should be on its way to trial shortly. The stockholders seem to be kept in the dark about these issues and the impending crisis.

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1591112, ~/Articles/ArticleHandler.aspx, 8/21/2014 2:30:21 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement